Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Fundacion Instituto De Investigacion Sanitaria Aragon
Sponsor

Fundacion Instituto De Investigacion Sanitaria Aragon

Spain Edificio Ciba, Avenida De San Juan Bosco 13, 50009 Zaragoza, Spain

About the sponsor

Research activity includes actinic keratoses and treatment of the surrounding field cancerisation, with interest in topical agents used alongside daylight photodynamic therapy.

  • Actinic keratoses
  • Field cancerisation
  • Topical metformin
  • Methyl aminolevulinate

Clinical work in this area is centred on cutaneous precancerous lesions and non-invasive dermatologic treatment approaches.

About Specializations

Fundacion Instituto De Investigacion Sanitaria Aragon runs clinical trials in conditions such as Cardiac failure acute, Colorectal cancer, Polypectomy, Actinic keratosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cardiac failure acute

Recruiting

Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon

Colorectal cancer

Recruiting

Study on the Effects of Aspirin and Omeprazole in Obese and Non-Obese Patients with Colorectal Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon

Polypectomy

Recruiting

Study on the Safety of Continuing Apixaban, Clopidogrel, and Rivaroxaban During Polyp Removal in Patients on Antiplatelet or Anticoagulant Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon

Actinic keratosis

Not yet recruiting

Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria Aragon

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.